News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,681 Results
Type
Article (45640)
Company Profile (715)
Press Release (669317)
Multimedia
Podcasts (130)
Webinars (23)
Section
Business (201335)
Career Advice (2269)
Deals (36658)
Drug Delivery (153)
Drug Development (81841)
Employer Resources (168)
FDA (16247)
Job Trends (15189)
News (342107)
Policy (30053)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2146)
Academic (1)
Accelerated approval (55)
ADA (46)
Adcomms (30)
Allergies (192)
Alliances (48498)
ALS (231)
Alzheimer's disease (1822)
Antibody-drug conjugate (ADC) (543)
Approvals (16683)
Artificial intelligence (729)
ASCO (336)
Autoimmune disease (358)
Automation (57)
Bankruptcy (383)
Best Places to Work (11281)
BIOSECURE Act (23)
Biosimilars (237)
Biotechnology (437)
Bladder cancer (203)
Brain cancer (78)
Breast cancer (792)
Cancer (6358)
Cardiovascular disease (507)
Career advice (1915)
Career pathing (47)
CAR-T (378)
CDC (30)
Celiac Disease (2)
Cell therapy (1049)
Cervical cancer (51)
Clinical research (71473)
Collaboration (2281)
Commercialization (1)
Company closure (7)
Compensation (1515)
Complete response letters (102)
COVID-19 (2595)
CRISPR (122)
C-suite (1268)
Cystic fibrosis (162)
Data (8577)
Decentralized trials (3)
Denatured (21)
Depression (183)
Dermatology (89)
Diabetes (647)
Diagnostics (7112)
Digital health (63)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (360)
Drug pricing (214)
Drug shortages (30)
Duchenne muscular dystrophy (302)
Earnings (89164)
Editorial (70)
Employer branding (24)
Employer resources (149)
Events (120908)
Executive appointments (1160)
FDA (20181)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (35)
Funding (1848)
Gene editing (262)
Generative AI (66)
Gene therapy (816)
GLP-1 (1147)
Government (3565)
Grass and pollen (8)
Guidances (404)
Healthcare (17394)
Hematology (193)
HIV (89)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (111)
Immunology and inflammation (329)
Immuno-oncology (113)
Indications (209)
Infectious disease (2961)
Inflammatory bowel disease (229)
Inflation Reduction Act (13)
Influenza (138)
Intellectual property (318)
Interviews (453)
IPO (17448)
IRA (52)
Job creations (4256)
Job search strategy (1558)
JPM (66)
Kidney cancer (22)
Labor market (105)
Layoffs (658)
Leadership (45)
Legal (7370)
Liver cancer (108)
Longevity (32)
Lung cancer (860)
Lymphoma (471)
Machine learning (62)
Management (60)
Manufacturing (1179)
Marketing (1)
MASH (217)
Medical affairs (1)
Medical device (14307)
Medtech (14468)
Mergers & acquisitions (20507)
Metabolic disorders (1660)
mRNA (251)
Multiple sclerosis (196)
NASH (20)
Neurodegenerative disease (479)
Neuropsychiatric disorders (124)
Neuroscience (3490)
Neurotech (1)
NextGen: Class of 2026 (6331)
Non-profit (3098)
Now hiring (80)
Obesity (773)
Opinion (339)
Ovarian cancer (233)
Pain (264)
Pancreatic cancer (349)
Parkinson's disease (397)
Partnered (35)
Patents (643)
Patient recruitment (759)
Peanut (68)
People (60464)
Pharmaceutical (125)
Pharmacy benefit managers (32)
Phase 1 (22595)
Phase 2 (31767)
Phase 3 (23565)
Pipeline (9642)
Policy (321)
Postmarket research (2106)
Preclinical (9644)
Press Release (69)
Prostate cancer (330)
Psychedelics (65)
Radiopharmaceuticals (366)
Rare diseases (1210)
Real estate (5958)
Recruiting (72)
Regulatory (24816)
Reports (46)
Research institute (2125)
Resumes & cover letters (349)
Rett syndrome (43)
RNA editing (26)
RSV (89)
Schizophrenia (190)
Series A (327)
Series B (237)
Service/supplier (25)
Sickle cell disease (128)
Special edition (31)
Spinal muscular atrophy (173)
Sponsored (44)
Startups (3992)
State (2)
Stomach cancer (20)
Supply chain (135)
Tariffs (100)
The Weekly (107)
Vaccines (1119)
Venture capital (127)
Weight loss (511)
Women's health (123)
Worklife (23)
Date
Today (108)
Last 7 days (536)
Last 30 days (2899)
Last 365 days (31429)
2026 (15711)
2025 (31196)
2024 (36472)
2023 (41098)
2022 (51629)
2021 (55233)
2020 (52432)
2019 (44184)
2018 (33615)
2017 (33522)
2016 (32115)
2015 (37701)
2014 (30398)
2013 (25666)
2012 (27122)
2011 (27231)
2010 (24752)
Location
Africa (749)
Alabama (100)
Alaska (7)
Arizona (295)
Arkansas (14)
Asia (43911)
Australia (7258)
California (14101)
Canada (3922)
China (1548)
Colorado (591)
Connecticut (616)
Delaware (435)
Europe (97012)
Florida (2050)
Georgia (431)
Hawaii (4)
Idaho (62)
Illinois (1053)
India (102)
Indiana (651)
Iowa (26)
Japan (584)
Kansas (138)
Kentucky (54)
Louisiana (50)
Maine (85)
Maryland (1541)
Massachusetts (10332)
Michigan (387)
Minnesota (775)
Mississippi (5)
Missouri (155)
Montana (35)
Nebraska (27)
Nevada (148)
New Hampshire (87)
New Jersey (3751)
New Mexico (33)
New York (3659)
North Carolina (1882)
North Dakota (10)
Northern California (7094)
Ohio (408)
Oklahoma (22)
Oregon (50)
Pennsylvania (2747)
Puerto Rico (31)
Rhode Island (54)
South America (1153)
South Carolina (85)
South Dakota (1)
Southern California (5505)
Tennessee (197)
Texas (2269)
United States (49615)
Utah (410)
Vermont (1)
Virginia (345)
Washington D.C. (77)
Washington State (1148)
West Virginia (4)
Wisconsin (143)
Wyoming (2)
715,681 Results for "cell culture company c3".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media
May 6, 2026
·
2 min read
Press Releases
Fujifilm and HORIBA Co-develop High-Sensitivity Inline Raman Measurement System for Real-Time Monitoring of Cell Culture and Purification in Biopharmaceutical Manufacturing
June 16, 2026
·
8 min read
Press Releases
Nu-Tek BioSciences Presents Data-Driven Approach to Animal Cell Culture Optimization at ESACT 2026
May 5, 2026
·
2 min read
Press Releases
Gene Therapy Cell Culture Media Market to Reach USD 600.11 Billion by 2035
April 23, 2026
·
1 min read
Press Releases
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
June 3, 2026
·
4 min read
Funding
NewLimit snags $435M after seeing age reversal in human liver cells
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
June 3, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
March 31, 2026
·
1 min read
Insights
From MSCs to iPSCs: building the cell therapy future
In this episode of Denatured, you’ll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and Jon Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT annual meeting. We dive into mesenchymal stem cells and induced pluripotent stem cells, exploring the science behind them, the manufacturing challenges, and the potential for scalable, engineered next-generation therapies.
May 14, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel) Securing Canadian rights to a proprietary advanced clinical-stage product candidate developed in Canada adds to Medexus’s medium-term product pipeline and helps build a North American allo-HSCT franchise
June 10, 2026
·
16 min read
Approvals
BeOne wins mantle cell lymphoma approval, opening new therapy class
Beqalzi is the first BCL2 inhibitor approved for relapsed or refractory mantle cell lymphoma.
May 14, 2026
·
2 min read
·
Tristan Manalac
1 of 71,569
Next
